Literature DB >> 18592005

Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint.

Lisa M Privette1, Jingly Fung Weier, Ha Nam Nguyen, Xiaochun Yu, Elizabeth M Petty.   

Abstract

CHFR is an E3 ubiquitin ligase and an early mitotic checkpoint protein implicated in many cancers and in the maintenance of genomic stability. To analyze the role of CHFR in genomic stability, by siRNA, we decreased its expression in genomically stable MCF10A cells. Lowered CHFR expression quickly led to increased aneuploidy due to many mitotic defects. First, we confirmed that CHFR interacts with the mitotic kinase Aurora A to regulate its expression. Furthermore, we found that decreased CHFR led to disorganized multipolar mitotic spindles. This was supported by the finding that CHFR interacts with alpha-tubulin and can regulate its ubiquitination in response to nocodazole and the amount of acetylated alpha-tubulin, a component of the mitotic spindle. Finally, we found a novel CHFR interacting protein, the spindle checkpoint protein MAD2. Decreased CHFR expression resulted in the mislocalization of both MAD2 and BUBR1 during mitosis and impaired MAD2/CDC20 complex formation. Further evidence of a compromised spindle checkpoint was the presence of misaligned metaphase chromosomes, lagging anaphase chromosomes, and defective cytokinesis in CHFR knockdown cells. Importantly, our results suggest a novel role for CHFR regulating chromosome segregation where decreased expression, as seen in cancer cells, contributes to genomic instability by impairing the spindle assembly checkpoint.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18592005      PMCID: PMC2435002          DOI: 10.1593/neo.08176

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  40 in total

1.  The fission yeast dma1 gene is a component of the spindle assembly checkpoint, required to prevent septum formation and premature exit from mitosis if spindle function is compromised.

Authors:  M Murone; V Simanis
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

2.  Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines.

Authors:  K A Myrie; M J Percy; J N Azim; C K Neeley; E M Petty
Journal:  Cancer Lett       Date:  2000-05-01       Impact factor: 8.679

3.  Chfr is required for tumor suppression and Aurora A regulation.

Authors:  Xiaochun Yu; Katherine Minter-Dykhouse; Liviu Malureanu; Wei-Meng Zhao; Dongwei Zhang; Carolin J Merkle; Irene M Ward; Hideyuki Saya; Guowei Fang; Jan van Deursen; Junjie Chen
Journal:  Nat Genet       Date:  2005-03-27       Impact factor: 38.330

4.  Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors.

Authors:  Kazuhiro Ogi; Minoru Toyota; Hiroaki Mita; Ayumi Satoh; Lisa Kashima; Yasushi Sasaki; Hiromu Suzuki; Kimishige Akino; Noriko Nishikawa; Makoto Noguchi; Yasuhisa Shinomura; Kohzoh Imai; Hiroyoshi Hiratsuka; Takashi Tokino
Journal:  Cancer Biol Ther       Date:  2005-07-06       Impact factor: 4.742

5.  Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.

Authors:  X Wang; Y-X Zhou; W Qiao; Y Tominaga; M Ouchi; T Ouchi; C-X Deng
Journal:  Oncogene       Date:  2006-05-22       Impact factor: 9.867

6.  Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells.

Authors:  Sean C Dowdy; Shujuan Jiang; X Clare Zhou; Xiaonan Hou; Fan Jin; Karl C Podratz; Shi-Wen Jiang
Journal:  Mol Cancer Ther       Date:  2006-11       Impact factor: 6.261

7.  Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.

Authors:  Lisa M Privette; Maria E González; Lei Ding; Celina G Kleer; Elizabeth M Petty
Journal:  Cancer Res       Date:  2007-06-27       Impact factor: 12.701

8.  Epigenetic inactivation of CHFR in human tumors.

Authors:  Minoru Toyota; Yasushi Sasaki; Ayumi Satoh; Kazuhiro Ogi; Takefumi Kikuchi; Hiromu Suzuki; Hiroaki Mita; Nobuyuki Tanaka; Fumio Itoh; Jean-Pierre J Issa; Kam-Wing Jair; Kornel E Schuebel; Kohzoh Imai; Takashi Tokino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

9.  Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase.

Authors:  Mark G Manfredi; Jeffrey A Ecsedy; Kristan A Meetze; Suresh K Balani; Olga Burenkova; Wei Chen; Katherine M Galvin; Kara M Hoar; Jessica J Huck; Patrick J LeRoy; Emily T Ray; Todd B Sells; Bradley Stringer; Stephen G Stroud; Tricia J Vos; Gabriel S Weatherhead; Deborah R Wysong; Mengkun Zhang; Joseph B Bolen; Christopher F Claiborne
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-23       Impact factor: 11.205

10.  The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.

Authors:  Tomokazu Fukuda; Yasuyuki Kondo; Hitoshi Nakagama
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

View more
  27 in total

Review 1.  Safeguarding entry into mitosis: the antephase checkpoint.

Authors:  Cheen Fei Chin; Foong May Yeong
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

2.  CHFR binds to and regulates MAD2 in the spindle checkpoint through its cysteine-rich domain.

Authors:  Jennifer A Keller; Elizabeth M Petty
Journal:  Biochem Biophys Res Commun       Date:  2011-05-07       Impact factor: 3.575

Review 3.  RNF8-dependent histone ubiquitination during DNA damage response and spermatogenesis.

Authors:  Teng Ma; Jennifer A Keller; Xiaochun Yu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2011-03-28       Impact factor: 3.848

4.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 5.  Whole chromosome instability and cancer: a complex relationship.

Authors:  Robin M Ricke; Janine H van Ree; Jan M van Deursen
Journal:  Trends Genet       Date:  2008-07-31       Impact factor: 11.639

6.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

7.  Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.

Authors:  Zheng Fu; Kevin Regan; Lizhi Zhang; Michael H Muders; Stephen N Thibodeau; Amy French; Yanhong Wu; Scott H Kaufmann; Wilma L Lingle; Junjie Chen; Donald J Tindall
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

8.  CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin.

Authors:  Sara A Wickström; Katarzyna C Masoumi; Saadi Khochbin; Reinhard Fässler; Ramin Massoumi
Journal:  EMBO J       Date:  2009-11-05       Impact factor: 11.598

Review 9.  Physiological and oncogenic Aurora-A pathway.

Authors:  Toshiaki Saeki; Mutsuko Ouchi; Toru Ouchi
Journal:  Int J Biol Sci       Date:  2009-11-26       Impact factor: 6.580

10.  ELM: the status of the 2010 eukaryotic linear motif resource.

Authors:  Cathryn M Gould; Francesca Diella; Allegra Via; Pål Puntervoll; Christine Gemünd; Sophie Chabanis-Davidson; Sushama Michael; Ahmed Sayadi; Jan Christian Bryne; Claudia Chica; Markus Seiler; Norman E Davey; Niall Haslam; Robert J Weatheritt; Aidan Budd; Tim Hughes; Jakub Pas; Leszek Rychlewski; Gilles Travé; Rein Aasland; Manuela Helmer-Citterich; Rune Linding; Toby J Gibson
Journal:  Nucleic Acids Res       Date:  2009-11-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.